Imunon Appoints James E. Dentzer to its Board of Directors

03.10.2022 - CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) - Imunon, Inc. (Nasdaq: IMNN), a clinical-stage drug development company, announces the appointment of James E. ... Seite 1

Related Keywords

Michaelh Tardugno ,Jamese Dentzer , ,Board Of Directors Curis Inc ,Imunon Inc Nasdaq ,Valeritas Inc ,Biogen Inc ,Amicus Therapeutics Inc ,Curis Inc ,Dicerna Pharmaceuticals Inc ,Chief Executive Officer ,Curi Chief Operating Officer ,Chief Financial ,From March ,Curi Chief Administrative Officer ,Chief Financial Officer ,Dicerna Pharmaceuticals ,Amicus Therapeutics ,Corporate Controller ,Pont De Nemours ,Executive Chairman ,